The Role of Organic Transporters in Pharmacokinetics and Nephrotoxicity of Newer Antiviral Therapies for HIV and Hepatitis C

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|16|4|322-331

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.16, Iss.4, 2015-01, pp. : 322-331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of new oral hepatitis C antiviral drugs

By Vispo Eugenia   Barreiro Pablo   Soriano Vicente  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 1, 2013-01 ,pp. : 5-16

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies

By Wong John B.  

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 661-672

Adis International

Access to resources Recommend Favorite

The Role of Drug Transporters in the Pharmacokinetics of Antibiotics

By  

Current Drug Metabolism, Vol. 17, Iss. 8, 2016-08 ,pp. : 799-805

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Viral Therapies for Hepatitis C Virus Infection: Current Options and Evolving Candidate Drugs

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 150-161

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapies for hepatitis C virus

By Birerdinc Aybike   Younossi Zobair M  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. : 535-544

Informa Healthcare

Access to resources Recommend Favorite